X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Novartis with Sterling Biotech - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs STERLING BIOTECH - Comparison Results

NOVARTIS    Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS STERLING BIOTECH NOVARTIS/
STERLING BIOTECH
 
P/E (TTM) x 347.8 -1.8 - View Chart
P/BV x 17.1 0.1 25,010.8% View Chart
Dividend Yield % 1.7 0.0 -  

Financials

 NOVARTIS   STERLING BIOTECH
EQUITY SHARE DATA
    NOVARTIS
Mar-16
STERLING BIOTECH
Dec-13
NOVARTIS/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs98211 9,352.4%   
Low Rs5563 16,358.8%   
Sales per share (Unadj.) Rs252.926.8 943.5%  
Earnings per share (Unadj.) Rs62.1-15.0 -415.5%  
Cash flow per share (Unadj.) Rs63.3-5.5 -1,158.6%  
Dividends per share (Unadj.) Rs10.000-  
Dividend yield (eoy) %1.30-  
Book value per share (Unadj.) Rs363.654.9 662.5%  
Shares outstanding (eoy) m31.96267.87 11.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.00.3 1,172.9%   
Avg P/E ratio x12.4-0.5 -2,663.4%  
P/CF ratio (eoy) x12.2-1.3 -955.1%  
Price / Book Value ratio x2.10.1 1,670.2%  
Dividend payout %16.10-   
Avg Mkt Cap Rs m24,5801,862 1,320.3%   
No. of employees `0000.81.4 55.5%   
Total wages/salary Rs m1,801547 329.4%   
Avg. sales/employee Rs Th10,748.95,303.3 202.7%   
Avg. wages/employee Rs Th2,395.2403.8 593.1%   
Avg. net profit/employee Rs Th2,641.1-2,959.0 -89.3%   
INCOME DATA
Net Sales Rs m8,0837,181 112.6%  
Other income Rs m82943 1,946.9%   
Total revenues Rs m8,9137,223 123.4%   
Gross profit Rs m234947 24.7%  
Depreciation Rs m372,543 1.4%   
Interest Rs m24,377 0.0%   
Profit before tax Rs m1,025-5,931 -17.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m170-   
Extraordinary Inc (Exp) Rs m1,6960-   
Tax Rs m752-1,924 -39.1%   
Profit after tax Rs m1,986-4,007 -49.6%  
Gross profit margin %2.913.2 22.0%  
Effective tax rate %73.432.4 226.1%   
Net profit margin %24.6-55.8 -44.0%  
BALANCE SHEET DATA
Current assets Rs m12,67814,335 88.4%   
Current liabilities Rs m2,43349,809 4.9%   
Net working cap to sales %126.7-494.0 -25.7%  
Current ratio x5.20.3 1,810.6%  
Inventory Days Days33403 8.1%  
Debtors Days Days22171 13.2%  
Net fixed assets Rs m6955,432 0.1%   
Share capital Rs m160268 59.6%   
"Free" reserves Rs m11,46013,935 82.2%   
Net worth Rs m11,62114,701 79.0%   
Long term debt Rs m09,478 0.0%   
Total assets Rs m14,40073,988 19.5%  
Interest coverage x570.5-0.4 -160,721.9%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x0.60.1 578.4%   
Return on assets %13.80.5 2,756.2%  
Return on equity %17.1-27.3 -62.7%  
Return on capital %23.6-6.4 -366.9%  
Exports to sales %0.725.9 2.9%   
Imports to sales %18.60.2 10,942.0%   
Exports (fob) Rs m601,860 3.2%   
Imports (cif) Rs m1,50312 12,317.2%   
Fx inflow Rs m1861,860 10.0%   
Fx outflow Rs m1,82125 7,315.4%   
Net fx Rs m-1,6351,835 -89.1%   
CASH FLOW
From Operations Rs m2,5311,719 147.3%  
From Investments Rs m-8,270-3,148 262.7%  
From Financial Activity Rs m-3861,426 -27.0%  
Net Cashflow Rs m-6,125-3 180,132.4%  

Share Holding

Indian Promoters % 0.0 33.9 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 2.0 0.0 -  
FIIs % 1.6 9.9 16.2%  
ADR/GDR % 0.0 16.9 -  
Free float % 21.5 39.3 54.7%  
Shareholders   41,647 21,482 193.9%  
Pledged promoter(s) holding % 0.0 55.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   FDC LTD.  UNICHEM LAB  DR. REDDYS LAB  AJANTA PHARMA  ALEMBIC LTD  

Compare NOVARTIS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Weak Finish to the Week Post Vishal Sikka's Exit as CEO of Infosys(Closing)

Share markets in India witnessed selling pressure, led by slump in shares of Infosys Ltd. after Vishal Sikka resigned as chief executive officer of the country's second-largest software services exporter.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Aug 18, 2017 (Close)

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE NOVARTIS WITH

MARKET STATS